Infectious Disease

A Wealth of Experience

We have collaborated with our clients on projects to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious disease.  Our experience includes:

  • Cholera
  • COVID-19
  • H1N1
  • Hepatitis
  • Herpes
  • Hospital-acquired infections
  • Human papillomavirus
  • Influenza
  • Invasive fungal infections
  • Malaria
  • Meningococcal disease
  • MRSA
  • Respiratory tract infections
  • Respiratory syncytial virus (RSV)
  • STDs
  • Vaccines

Types of Projects

We have implemented studies to help our clients develop strategies in the infectious disease market and to develop and gain market access for products to treat infectious diseases and complications arising from treatment of infectious diseases.

Recent projects have included:

Our Experts

Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Alicia Gilsenan
Senior Director and Head, Epidemiology
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Bintu Sherif
Director, Biostatistics
Daniel Mines
Senior Director, Epidemiology
William L Herring
Senior Director, Health Economics
Keith Davis
Senior Director, Health Economics
Alejandro Arana
Senior Director, Epidemiology
Sandra Talbird
Senior Director, Health Economics
Catherine Joan Masaquel
Senior Director, Market Access and Outcomes Strategy
Elizabeth B. Andrews
Vice President, Emeritus, Epidemiology
Stephanie Earnshaw
Senior Vice President, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Katherine Hicks
Senior Director, Health Economics
Dee Dee Mladsi (she/her)
Head, Health Economics—Strategy and Early Modeling
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Michele Wilson
Senior Director, Health Economics
Jonathan Graham
Director, Health Economics
Christine Poulos
Senior Economist and Global Head, Health Preference Assessment
Juliana Meyers
Director, Health Economics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Marco Boeri
Senior Economist
Josephine Mauskopf
Vice President, Health Economics

Selected Recent Infectious Disease Publications